Loading...
Management of Pediatric Systemic Lupus Erythematosus: Focus on Belimumab
Belimumab (Benlysta(®)) is a fully humanized monoclonal antibody that inhibits B lymphocyte stimulator (BLyS, also known as B cell-activating factor of the tumor necrosis factor family) and was approved by the US Food and Drug Administration (FDA) and the European Medicines Evaluation Agency for the...
Na minha lista:
| Udgivet i: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7323799/ https://ncbi.nlm.nih.gov/pubmed/32612353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S216193 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|